Paulo Henrique Rosado de Castro, MD, PhD, MSc, MBA, is an incoming Clinical Assistant Professor at the Division of Nuclear Medicine at the Deparment of Radiology at the University of Iowa, with a start date of January 1st, 2026. He is currently a Nuclear Medicine Physician in Brazil, with clinical licensure in Brazil and a Special License from the Iowa Board of Medicine. His academic mission is to advance molecular imaging for oncologic, neurologic, and cardiopulmonary diseases, integrating rigorous clinical research with translation to practice; he focuses on how PET/CT and SPECT/CT can clarify disease biology and guide therapy, with differentiators that include cross-domain expertise spanning oncology (PSMA, neuroendocrine tumors), infection/inflammation (tuberculosis, COVID-19), and cardiovascular/neurologic imaging. Dr. Rosado de Castro has authored 60+ peer-reviewed works overall (68 works indexed on Google Scholar) with more than 2,000 citations and an H-index of 23 (Google Scholar), complemented by convergent metrics on Web of Science (H-index 20; 1,356 citations) and Scopus (H-index 20; 1,473 citations). He has delivered invited presentations in national and international venues and maintains active membership in professional societies. Beyond authorship, he contributes extensively to the scholarly ecosystem as a reviewer and editor, having served as a peer reviewer for numerous journals, including Molecular Imaging and Biology, PLoS One, Journal of Translational Medicine, Acta Neurologica Scandinavica, CNS Neuroscience & Therapeutics, PAIN Reports, Frontiers in Neurology, European Journal of Radiology, Radiologia Brasileira, and Archives of Endocrinology and Metabolism, and has also held guest editor and editorial board roles. His long-term goals are to develop evidence-based imaging pathways and theranostic strategies that improve patient outcomes in prostate cancer, neuroendocrine tumors, and inflammatory/infectious diseases, while expanding quantitative imaging methods (e.g., PET-based volumetrics and radiotracer kinetics) and collaborating on multicenter clinical trials that bridge bench discoveries and bedside decision-making. Dr. Rosado de Castro’s distinctive professional strengths include calm, active listening and clear communication with multidisciplinary teams; mentorship and leadership grounded in empathy and accountability; program and operations management experience across academic and hospital settings; and analytical problem-solving that connects image-based biomarkers to clinically actionable questions. He has served as Chief of the Nuclear Medicine Service at the Clementino Fraga Filho University Hospital at the Federal University of Rio de Janeiro and Medical Director for the CRO Perceptive, and through formal training that includes an MBA in Advanced Management Development. Outside of work, he enjoys family time, distance running, exploring museums and local cuisine during conference travel, and mentoring trainees, pursuits that reflect his belief that curiosity, service, and balance sustain a meaningful academic life.